Rui Melo has extensive experience in business development and client management within the pharmaceutical and clinical trial sectors. Currently serving as the Director of Business Development and Client Management at CTI Clinical Trial and Consulting Services since November 2017, Rui has been instrumental in the approval of numerous new drugs and devices globally. Past roles include Executive Director at COMPERIO, where responsibilities spanned R&D consulting across various medical sectors, and Director of New Business & Alliances at Eurotrials prior to its acquisition by CTI. Rui's career also includes significant positions at iCardiac Technologies and ERT, focusing on cardiac safety and clinical outcome assessments. Educational qualifications include degrees in Biology, Pharmaco-epidemiology, and Business Administration, underscoring a strong foundation in both scientific and business principles.